Format

Send to

Choose Destination
Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):328-329. doi: 10.1093/ehjqcco/qcx044.

Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation.

Author information

1
Department of Pharmacy Practice, University of Connecticut School of Pharmacy, 69 North Eagleville Road, Unit 3092, Storrs, Connecticut, USA.
2
Evidence-Based Practice Center, Hartford Hospital, 80 Seymour Street, Hartford, CT, USA.
3
Clinical Pharmacy and Outcome Sciences, Medical University of South Carolina College of Pharmacy, 171 Ashley Avenue, Charleston, SC, USA.
4
Department of Pharmacy Practice, Idaho State University College of Pharmacy, 921 S. 8th Avenue, Stop 8288 , Pocatello, Idaho, USA.
5
Department of Pharmacoepidemiology, New England Health Analytics, LLC, 54 Old Stagecoach Road, Granby, CT, USA.
6
Department of Cardiac Electrophysiology, Southcoast Health System, Fall River, MA, USA.
PMID:
29121212
DOI:
10.1093/ehjqcco/qcx044
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center